These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 33964375)

  • 21. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.
    Yu L; Qiao R; Xu J; Han B; Zhong R
    Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y; Wang M; Liu B
    J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRKCB is relevant to prognosis of lung adenocarcinoma through methylation and immune infiltration.
    Wang J; Shi M; Zhang H; Zhou H; Huang Z; Zhou Y; Shi J
    Thorac Cancer; 2022 Jun; 13(12):1837-1849. PubMed ID: 35567329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma.
    Yu Y; Wang Z; Zheng Q; Li J
    Aging (Albany NY); 2021 Mar; 13(6):8155-8176. PubMed ID: 33686947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive Analysis of YTH Domain Family in Lung Adenocarcinoma: Expression Profile, Association with Prognostic Value, and Immune Infiltration.
    Hu K; Yao L; Yan Y; Zhou L; Li J
    Dis Markers; 2021; 2021():2789481. PubMed ID: 34497675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.
    Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L
    Front Immunol; 2021; 12():723172. PubMed ID: 34539658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of GCLC in prognosis and immunity of lung adenocarcinoma and multi-omics regulation mechanisms.
    Huang Z; Liang F; Wu J; Huang Z; Li Y; Huang X; Liu Z
    BMC Pulm Med; 2024 May; 24(1):239. PubMed ID: 38750474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GREB1L overexpression correlates with prognosis and immune cell infiltration in lung adenocarcinoma.
    Yu Y; Wang Z; Zheng Q; Li J
    Sci Rep; 2021 Jun; 11(1):13281. PubMed ID: 34168239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
    Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
    Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
    Dong M; Yang Z; Li X; Zhang Z; Yin A
    Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma.
    Zhang YH; Zeng J; Liu XS; Gao Y; Kui XY; Liu XY; Zhang Y; Pei ZJ
    Front Endocrinol (Lausanne); 2022; 13():1013238. PubMed ID: 36299451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LINC00467 Is Upregulated by DNA Copy Number Amplification and Hypomethylation and Shows ceRNA Potential in Lung Adenocarcinoma.
    Wang W; Bo H; Liang Y; Li G
    Front Endocrinol (Lausanne); 2021; 12():802463. PubMed ID: 35095769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant CpG-methylation affects genes expression predicting survival in lung adenocarcinoma.
    He W; Ju D; Jie Z; Zhang A; Xing X; Yang Q
    Cancer Med; 2018 Nov; 7(11):5716-5726. PubMed ID: 30353687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
    Zhao Y; Gao Y; Xu X; Zhou J; Wang H
    BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation- and homologous recombination deficiency-related mutant genes predict the prognosis of lung adenocarcinoma.
    Nie GJ; Liu J; Zou AM; Zhan SF; Liang JK; Sui Y; Chen YN; Yao WS
    J Clin Lab Anal; 2022 Apr; 36(4):e24277. PubMed ID: 35238419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant expression of GSTM5 in lung adenocarcinoma is associated with DNA hypermethylation and poor prognosis.
    Hao X; Zhang J; Chen G; Cao W; Chen H; Chen S
    BMC Cancer; 2022 Jun; 22(1):685. PubMed ID: 35729618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
    Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
    Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma.
    Cai J; Deng H; Luo L; You L; Liao H; Zheng Y
    Aging (Albany NY); 2020 Dec; 13(2):2073-2088. PubMed ID: 33323549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Prognostic DNA Methylation Signatures in Lung Adenocarcinoma.
    Wang P; Xu G; Gao E; Xu Y; Liang L; Jiang G; Duan L
    Oxid Med Cell Longev; 2022; 2022():8802303. PubMed ID: 35814273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide analysis of methylation CpG sites in gene promoters identified four pairs of CpGs-mRNAs associated with lung adenocarcinoma prognosis.
    Pan X; Ji P; Deng X; Chen L; Wang W; Li Z
    Gene; 2022 Feb; 810():146054. PubMed ID: 34737001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.